期刊文献+

血塞通联合利伐沙班预防下肢骨折术后深静脉血栓形成的疗效及对患者血液流变学的影响 被引量:18

Curative efficacy of xuesaitong injection in combination with rivaroxaban and its effects on hemorheology in prevention of deep venous thrombosis after operation of lower limb fracture
在线阅读 下载PDF
导出
摘要 目的探讨血塞通联合利伐沙班预防下肢骨折术后深静脉血栓(DVT)形成的疗效及对患者血液流变学的影响。方法 100例符合纳入标准的下肢骨折术后患者随机分为两组,每组各50例。对照组给予血塞通治疗;观察组在对照组的基础上联合使用利伐沙班治疗。疗程结束后,比较两组患者DVT发生率、DVT早期诊断指标及血液流变学情况。结果观察组DVT的发生率为8.0%,明显低于观察组44.0%的DVT发生率,两组相比较差异有统计学意义(P<0.05)。术后3天,与对照组相比,观察组DVT早期诊断指标D-dimer、同型半胱氨酸和CRP明显降低,比较差异有统计学意义(P<0.05)。血液流变学方面,观察组治疗后红细胞压积、全血黏度和纤维蛋白原较对照组明显降低,比较差异有统计学意义(P<0.05)。结论血塞通联合利伐沙班是预防下肢骨折术后DVT发生的有效方案,可以明显降低DVT发生率,显著降低DVT的早期诊断指标,并改善患者血液高凝状态,值得临床上进一步研究及推广。 【Objective】To investigate the clinical effect of xuesaitong injection in combination with rivaroxaban and its effects on hemorheology in the prevention of deep venous thrombosis(DVT) after operation of lower limbs fractures. 【Methods】A total of 100 cases with operation of lower limb fractures meeting the inclusion criteria were randomly divided into two groups with equal number. The cases in the control group were treated with xuesaitong injection while those in the observation group were treated with xuesaitong injection and rivaroxaban. The incidence of DVT, early diagnostic indices of DVT and hemorheology indices were observed and compared.【Results】The observation group had a total DVT incidence of 8.0%, which was statistically lower than that of 44.0% in the control group(P〈0.05). Three days after the operation, D-dimer, homocysteine and CRP which reflect early diagnosis of DVT in the observation group were statistically lower than those in the control group(P〈0.05). As to hemorheology indices, in comparison to the control group, hematocrit, whole blood viscosity and fibrinogen in the observation group were statistically lower(P〈0.05).【Conclusions】After operation of lower limbs fractures, the treatment with a combination of xuesaitong injection and rivaroxaban for the prevention of DVT is reliable, which could significantly reduce the incidence of DVT, decrease early diagnostic indices of DVT and alleviate blood hyper-coagulation.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第3期75-78,共4页 China Journal of Modern Medicine
关键词 血塞通 利伐沙班 下肢骨折 深静脉血栓 血液流变学 xuesaitong rivaroxaban lower limb fracture deep venous thrombosis hemorheology
  • 相关文献

参考文献17

二级参考文献132

共引文献256

同被引文献190

  • 1金玉青,洪远林,李建蕊,李曦,王晓晓,吕光华.川芎的化学成分及药理作用研究进展[J].中药与临床,2013,4(3):44-48. 被引量:387
  • 2邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:429
  • 3陆芸,马宝通,郭若霖,张建国,吴英华,庞贵根,辛景义,叶伟胜,邹玉安,王毅,董强,王学谦,Kerry H,Paul C,John F.骨科创伤患者深静脉血栓危险因素的研究[J].中华骨科杂志,2007,27(9):693-698. 被引量:245
  • 4Kwong LM.Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery:focus on rivaroxaban[J].Clin Pharmacol,2013,5(5):143-148.
  • 5Raskob GE,Silverstein R,Bratzler DW,et al.Surveillance for deep vein thrombosis and pulmonary embolism:recommendations from a national workshop[J].Am J Prev Med,2010,38(Suppl):S502-S509.
  • 6Kohyama K,Hashimoto M,Abe S,et al.Thromboxane A2 receptor+795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells-466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease[J].Mol Med Report,2012,5(2):477-482.
  • 7Maron BA,Bhatt DL,Nykiel M,et al.Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension[J].Crit Pathw Cardiol,2012,11(1):40-42.
  • 8Hall SM,Davie N,Klein N,et al.Endothelin receptor expression in idiopathic pulmonary arterial hypertension:effect of bosentan and epoprostenol treatment[J].Eur Respir J,2011,38(4):851-860.
  • 9Jiang J,Hu Y,Hu P,et al.Safety,pharmacokinetics and pharmacodynamics of single doses of rivaroxaban-an oral,direct factor Xa inhibitor-in elderly Chinese subjects[J].Thromb Haemost,2010,103(1):234-241.
  • 10Eriksson BI,Borris LC,Friedman RJ,et al.Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty[J].N Engl J Med,2008,358(26):2765-2775.

引证文献18

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部